Terms: = Ovarian cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
1189 results:
1. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
2. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
[TBL] [Abstract] [Full Text] [Related]
3. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites.
Hrvat A; Benders S; Kimmig R; Brandau S; Mallmann-Gottschalk N
Front Immunol; 2024; 15():1360615. PubMed ID: 38646521
[TBL] [Abstract] [Full Text] [Related]
4. Successful Treatment of a Case of Crescentic Glomerulonephritis in a Patient with Primary Peritoneal Carcinoma: A case report.
Zribi A; Nagy A; Riyami MA; Burney IA
Sultan Qaboos Univ Med J; 2024 Feb; 24(1):119-122. PubMed ID: 38434475
[TBL] [Abstract] [Full Text] [Related]
5. VNP20009-Abvec-Igκ-MIIP suppresses ovarian cancer progression by modulating Ras/MEK/ERK signaling pathway.
Wang Q; Tang Y; Dai A; Li T; Pei Y; Zhang Z; Hu X; Chen T; Chen Q
Appl Microbiol Biotechnol; 2024 Feb; 108(1):218. PubMed ID: 38372808
[TBL] [Abstract] [Full Text] [Related]
6. Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the egfr pathway.
Sarı U; Zaman F
Acta Cir Bras; 2024; 39():e390524. PubMed ID: 38324801
[TBL] [Abstract] [Full Text] [Related]
7. Combination of Osimertinib and Olaparib Therapy to Treat Non-Small Cell Lung cancer and High-Grade Serous ovarian Carcinoma: A Case Report.
Lin J; Welch S; Sanatani M; Ramadan S
Curr Oncol; 2024 Jan; 31(1):558-565. PubMed ID: 38275832
[TBL] [Abstract] [Full Text] [Related]
8. 8-Br-cGMP suppresses tumor progression through egfr/PLC γ1 pathway in epithelial ovarian cancer.
Wu M; Mu C; Yang H; Wang Y; Ma P; Li S; Wang Z; Lan T
Mol Biol Rep; 2024 Jan; 51(1):140. PubMed ID: 38236447
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Analysis of MICALL2 Reveals Its Potential Roles in egfr Stabilization and ovarian cancer Cell Invasion.
Xia T; Ye F; Zhao W; Min P; Qi C; Wang Q; Zhao M; Zhang Y; Du J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203692
[TBL] [Abstract] [Full Text] [Related]
10. Pan-egfr Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in ovarian cancer SKOV3-TR Cells.
Lim YJ; Kim HS; Bae S; So KA; Kim TJ; Lee JH
Molecules; 2024 Jan; 29(1):. PubMed ID: 38202856
[TBL] [Abstract] [Full Text] [Related]
11. Increase in creatinine levels associated with niraparib maintenance therapy in ovarian cancer.
Takahashi Y; Taguchi M; Tamura K; Shinohara M; Koyanagi T; Takahashi S; Taneichi A; Takei Y; Saga Y; Fujiwara H
J Obstet Gynaecol Res; 2024 Mar; 50(3):501-507. PubMed ID: 38115203
[TBL] [Abstract] [Full Text] [Related]
12. Giant left pheochromocytoma with vascular anomalies and pelvic horseshoe kidney: a case report.
Biben E; Menon L; Gokden N; Spond MF; Eichhorn JM; Aydin AM
BMC Urol; 2023 Dec; 23(1):204. PubMed ID: 38066479
[TBL] [Abstract] [Full Text] [Related]
13. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
14. Serum human epididymis protein 4 is associated with disease severity in patients with IgA nephropathy.
Luo HL; He C; Xue H; Li M; Ji L; Xia Y
Clin Biochem; 2024 Jan; 123():110701. PubMed ID: 38048899
[TBL] [Abstract] [Full Text] [Related]
15. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of egfr.
Bapat J; Yamamoto TM; Woodruff ER; Qamar L; Mikeska RG; Aird KM; Watson ZL; Brubaker LW; Bitler BG
Cancer Gene Ther; 2024 Feb; 31(2):300-310. PubMed ID: 38030811
[TBL] [Abstract] [Full Text] [Related]
16. Modulatory effect of pomegranate peel extract on key regulators of ovarian cellular processes
Kolesarova A; Baldovska S; Kohut L; Vasicek J; Ivanisova E; Arvay J; Duracka M; Roychoudhury S
Front Endocrinol (Lausanne); 2023; 14():1277155. PubMed ID: 38027211
[TBL] [Abstract] [Full Text] [Related]
17. An Aptamer-Based Nanoflow Cytometry Method for the Molecular Detection and Classification of ovarian cancers through Profiling of Tumor Markers on Small Extracellular Vesicles.
Li J; Li Y; Li Q; Sun L; Tan Q; Zheng L; Lu Y; Zhu J; Qu F; Tan W
Angew Chem Int Ed Engl; 2024 Jan; 63(4):e202314262. PubMed ID: 38012811
[TBL] [Abstract] [Full Text] [Related]
18. Expression of egfr, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.
Nikas IP; Park SY; Song MJ; Lee C; Ryu HS
Diagn Cytopathol; 2024 Feb; 52(2):69-75. PubMed ID: 37937321
[TBL] [Abstract] [Full Text] [Related]
19. The Network Pharmacology Analysis of Tonifying Yang Formula for the Treatment of Diminished ovarian Reserve.
Ma Q; Wu X; Chen D; Li W; Wu J; Shen M; Ye C; Tan Y; Guo Q
Altern Ther Health Med; 2024 Mar; 30(3):176-184. PubMed ID: 37883761
[TBL] [Abstract] [Full Text] [Related]
20. egfr-targeted humanized single chain antibody fragment functionalized silica nanoparticles for precision therapy of cancer.
Wu H; Ding X; Chen Y; Cai Y; Yang Z; Jin J
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127538. PubMed ID: 37866562
[TBL] [Abstract] [Full Text] [Related]
[Next]
